These findings from western blot analysis were confirmed using RT-PCR to identify the expression of Sox2 and Twist1 along with other glioma stem cell markers in a panel of seven hGBM specimens (Fig. 1F). The gene discussed is TWIST1; the disease is central nervous system cancer.